Comparison of three monoclonal antibody pools for the detection of respiratory viral antigen in respiratory secretions.
The aim of this study was to compare the sensitivities of commercial monoclonal antibody pools to be used as an initial rapid screen for detection of viral antigens in respiratory secretions. The availability of commercial monoclonal antibodies has dramatically improved the detection of viruses by immunofluorescence techniques in exfoliated cells obtained from respiratory secretions. Several companies have recently introduced monoclonal antibody pools to detect the presence of respiratory viruses in a single preparation. Ninety-four stored slide preparations that had previously been examined by individual monoclonal antibodies were tested using three commercial monoclonal antibody pools produced by Sanofi (UK), Dako (UK), and Quadratech (UK). These monoclonal antibody pools had a sensitivity of 79.6%, 90.9%, and 100%, respectively, when compared with the original results. The overall intensity of immunofluorescence was also examined.
Taylor
P
P
Department of Microbiology, Virology, Royal Brompton and Harefield NHS Trust, London, UK.
Dave
J R
JR
Gaya
H
H
D000911:Antibodies, Monoclonal / Q000276:immunology*; D000956:Antigens, Viral / Q000032:analysis*; D005455:Fluorescent Antibody Technique; D006801:Humans; D011933:Reagent Kits, Diagnostic; D012141:Respiratory Tract Infections / Q000821:virology*; D012189:Retrospective Studies; D013183:Sputum / Q000821:virology*
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral; D011933:Reagent Kits, Diagnostic